MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

SARS-CoV-2 infection exacerbates the cellular pathology in Parkinson’s disease progression

HN. Choi, BN. Lee, YH. Che, MG. Ko, HM. Seong, MG. Jo, KS. Lyoo, YJ. Kim, SP. Yun (Jin-Ju, Republic of Korea)

Meeting: 2023 International Congress

Abstract Number: 1460

Keywords: Dopaminergic neurons, Parkinson’s

Category: Parkinson's Disease: Molecular Mechanisms of Disease

Objective: This study can provide an important insight for identification and prediction of long term neurological sequelae of SARS-CoV-2 infection and proper clinical management the survivors.

Background: Parkinson’s disease (PD) is closely linked to immune responses induced by microbial infections such as Herpes virus, Helicobacter pylori, hepatitis C virus, or pneumococcus. However, the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the onset and progression of PD is yet to be investigated. At the tail end of the current COVID-19 pandemic, it is critical to predict and prepare for the biologically possible neurological sequelae of SARS-CoV-2 infection.

Method: We differentiated human embryonic stem cells to dopaminergic (DA) neurons, which was subsequently infected with SARS-CoV-2.

Results: SARS-CoV-2, in vitro, increased pre-formed fibril (PFF)-mediated cytotoxicity on DA neuron but also elevated susceptibility to PFF-induced PD-like pathology. Reflecting this phenotype, RNA sequencing of SARS-CoV-2 infected DA neurons demonstrated changes in expressions of signalling molecules in apoptosis, autophagy, oxidative stress, and mitochondrial function. Next, we found that SARS-CoV-2 was successfully detected in the brains of human angiotensin-converting enzyme 2 transgenic (hACE2 Tg) mice that were intra-nasally infected with SARS-CoV-2. And SARS-CoV-2 infection further amplified inflammatory response in microglia and astrocytes in comparison to PFF treatment alone, which was, to our surprise, maintained for 60 days even after complete clearance SARS-CoV-2 from the brain. Furthermore, while SARS-CoV-2 infection alone was unable to exert cytotoxic effect on DA neurons, it increased susceptibility of PFF-induced DA neuronal death.

Conclusion: Based on these results, we suggest a previously unappreciated paradigm that neuroinflammation triggered by SARS-CoV-2 infection persists in the brain after viral clearance and can increase susceptibility to PD a long-term sequela.

To cite this abstract in AMA style:

HN. Choi, BN. Lee, YH. Che, MG. Ko, HM. Seong, MG. Jo, KS. Lyoo, YJ. Kim, SP. Yun. SARS-CoV-2 infection exacerbates the cellular pathology in Parkinson’s disease progression [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/sars-cov-2-infection-exacerbates-the-cellular-pathology-in-parkinsons-disease-progression/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/sars-cov-2-infection-exacerbates-the-cellular-pathology-in-parkinsons-disease-progression/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley